Venture capital firm focused on early-stage and growth-stage technology investments.
Verified emails & LinkedIn for founders across this portfolio.
Glean develops an AI-based search engine software that connects enterprise data and generates answers to improve workplace efficiency.
TenSixty BioSciences' goal is to identify novel small molecule therapeutics made possible by combining high throughput experiments.
Thea is an AI-powered skincare and dermatology app that gives personalized skincare advice, product recommendations.
Odyssey Therapeutics creates precision immunomodulators and oncology medicines for patients with cancer and inflammatory diseases.
Kouper Health is a healthcare company that uses EHR integration, machine learning, and automation to improve transitions of care.
ParcelBio develops biotechnology focused on RNA medicine delivery systems and therapeutic development platforms.
Ethos is an AI-driven platform that matches individuals with opportunities.
Nace AI develops enterprise AI systems that automate complex professional workflows by generating task-specific AI models.
Material Bank provides sample materials for design professionals and brands in the architecture and design industry.
Hona AI is an AI data platform that collects and maintains healthcare history and records of patients.
Mark43 offers cloud-based public safety software for law enforcement to ensure accurate responses.
EthonAI is an AI-powered platform that detects and prevents manufacturing defects.
Geordie AI is an AI governance platform, helping enterprises adopt AI agents while managing posture, observability, and compliance.
Anthropic is an artificial intelligence company that develops large language models and AI systems for business and research use.
Context frees up teams to focus on higher-value strategies by drafting, analyzing, visualizing, and distributing work.
Cognition develops artificial intelligence systems for software engineering and code automation.
Optimizing cell therapy with spatial biology
Triomics is a generative AI-powered platform that matches patients to clinical trials.
Lucis combines lab testing, wearable data, and health insights to help individuals understand and improve their biology.
Jadu builds next-gen augmented reality games and the technology that makes them accessible on mobile devices.
Karius delivers genomic insights into infectious diseases, helping clinicians make critical, life-saving treatment decisions.
Modal is a serverless cloud infrastructure platform for running machine learning and data processing workloads.
ICEYE operates a radar satellite constellation, providing all weather earth observation data and analytics for industries.
Catena Labs incubate independent products spanning identity, communications, AI, and commerce.
General Catalyst has invested in 1,137 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
General Catalyst's top investment sectors include Artificial Intelligence (AI), Generative AI, Health Care, Software, Information Technology. The firm invests across 59 different industry categories.
Among tracked funding rounds, Cognition received $1.0B in a Series D round. General Catalyst's total known invested capital is $95.5B.
General Catalyst's average investment size is $102.5M across its portfolio of 1,137 companies.
Recent General Catalyst portfolio additions include Glean, TenSixty BioSciences, Thea, Odyssey Therapeutics, Kouper Health. These companies were founded in 2020 or later.